Summary.
Two-fold immunization of Balb/c mice with a vaccinia virus recombinant expressing the NP protein of influenza A/PR8/34 (H1N1) virus under the control of a strong synthetic promoter induced specific antibodies and protected animals against low-dose challenge by mouse-adapted heterosubtypic variants of human A/Aichi2/68 (H3N2) and avian A/Mallard/Pennsylvania/10218/84 (H5N2) influenza virus strains. The surviving immunized animals had lower anti-hemagglutinin antibody titers compared to non-immunized mice. There was no difference in viral titers in lungs of immunized and non-immunized animals that succumbed to the infection. In order to try to increase immune system presentation of NP-protein-derived peptides, and thereby increase their immunogenicity, we constructed another vaccinia-based NP-expressing recombinant containing a rapid proteolysis signal covalently bound to the NP protein. This sequence, derived from the mouse ornithine decarboxylase gene has been shown to increase degradation of various proteins. However, we found that when used as part of a recombinant NP, this signal neither increased its proteolytic degradation, nor was it more efficient in the induction of a protective response against influenza infection.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
ME Andrew BE Coupar GL Ada DB Boyle (1986) ArticleTitleCell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants Microb Pathog 1 443–452 Occurrence Handle1:STN:280:BiaB3sjot1M%3D Occurrence Handle3509883
ME Andrew BE Coupar DB Boyle GL Ada (1987) ArticleTitleThe roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants Scand J Immunol 25 21–28 Occurrence Handle1:STN:280:BiiC38%2FgvVU%3D Occurrence Handle3492756
ME Andrew BE Coupar (1988) ArticleTitleEfficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice Scand J Immunol 28 81–85 Occurrence Handle1:STN:280:BieB1M%2FltlA%3D Occurrence Handle2456608
LC Anton U Schubert I Bacik MF Princiotta PA Wearsch J Gibbs PM Day C Realini MC Rechsteiner JR Bennink JW Yewdell (1999) ArticleTitleIntracellular localization of proteasomal degradation of a viral antigen J Cell Biol 146 113–124 Occurrence Handle1:CAS:528:DyaK1MXksFCjs74%3D Occurrence Handle10402464
JR Bennink JW Yewdell GL Smith B Moss (1987) ArticleTitleAnti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled J Virol 61 1098–1102 Occurrence Handle1:CAS:528:DyaL2sXhvFCht7o%3D Occurrence Handle3493353
VM Braud AJ McMichael V Cerundolo (1998) ArticleTitleDifferential processing of influenza nucleoprotein in human and mouse cells Eur J Immunol 28 625–635 Occurrence Handle10.1002/(SICI)1521-4141(199802)28:02<625::AID-IMMU625>3.0.CO;2-I Occurrence Handle1:CAS:528:DyaK1cXhsFGgsbo%3D Occurrence Handle9521073
Z Chen S Kadowaki Y Hagiwara T Yoshikawa K Matsuo T Kurata S Tamura (2001) ArticleTitleProtection against influenza B virus infection by immunization with DNA vaccines Vaccine 19 1446–1455 Occurrence Handle1:CAS:528:DC%2BD3MXktl2jsg%3D%3D Occurrence Handle11163667
Z Chen Y Sahashi K Matsuo H Asanuma H Takahashi T Iwasaki Y Suzuki C Aizawa T Kurata S Tamura (1998) ArticleTitleComparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza Vaccine 16 1544–1549 Occurrence Handle10.1016/S0264-410X(98)00043-7 Occurrence Handle1:CAS:528:DyaK1cXlsFahtrc%3D Occurrence Handle9711802
Z Chen T Yoshikawa S Kadowaki Y Hagiwara K Matsuo H Asanuma C Aizawa T Kurata S Tamura (1999) ArticleTitleProtection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein J Gen Virol 80 2559–2564 Occurrence Handle1:CAS:528:DyaK1MXmsVygsLY%3D Occurrence Handle10573147
AK Gitelman NV Kaverin IG Kharitonenkov IA Rudneva VM Zhdanov (1984) ArticleTitleChanges in the antigenic specificity of influenza hemagglutinin in the course of adaptation to mice Virology 134 230–232 Occurrence Handle10.1016/0042-6822(84)90288-5 Occurrence Handle1:STN:280:BiuC2svgvV0%3D Occurrence Handle6200993
C Gschoesser G Almanzar U Hainz J Ortin D Schonitzer H Schild M Saurwein-Teissl B Grubeck-Loebenstein (2002) ArticleTitleCD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein Vaccine 20 3731–3738 Occurrence Handle10.1016/S0264-410X(02)00355-9 Occurrence Handle1:CAS:528:DC%2BD38XotVWhu7g%3D Occurrence Handle12399202
KJ Jakeman H Smith C Sweet (1989) ArticleTitleMechanism of immunity to influenza: maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins J Gen Virol 70 1523–1531 Occurrence Handle2732721
NV Kaverin IA Rudneva NA Ilyushina NL Varich AS Lipatov YA Smirnov EA Govorkova AK Gitelman DK Lvov RG Webster (2002) ArticleTitleStructure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants J Gen Virol 83 2497–2505 Occurrence Handle1:CAS:528:DC%2BD38XnsFKgu7c%3D Occurrence Handle12237433
Kilbourne ED, Arden NH (1999) Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA (eds) Vaccines. W.B. Saunders Company, Philadelphia, pp 531–551
MV Khoretonenko MF Vorovitch LG Zakharova GV Pashvykina NV Ovsyannikova JR Stephenson AV Timofeev AD Altstein AM Shneider (2003) ArticleTitleVaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice Immunol Lett 90 161–163 Occurrence Handle10.1016/j.imlet.2003.09.002 Occurrence Handle1:CAS:528:DC%2BD3sXpvVajs70%3D Occurrence Handle14687719
S Kodihalli DL Kobasa RG Webster (2000) ArticleTitleStrategies for inducing protection against avian influenza A virus subtypes with DNA vaccines Vaccine 18 2592–2599 Occurrence Handle10.1016/S0264-410X(99)00485-5 Occurrence Handle1:CAS:528:DC%2BD3cXkt1Crs7g%3D Occurrence Handle10775793
Lamb RA, Krug RM (2001) Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, v.1. Lippincot, Williams, Wilkins, Philadelphia, USA, pp 1487–1531
AS Lipatov EA Govorkova RJ Webby H Ozaki M Peiris Y Guan L Poon RG Webster (2003) ArticleTitleInfluenza: emergence and control J Virol (2004) 78 8951–8959
P Loetscher G Pratt M Rechsteiner (1991) ArticleTitleThe C terminus of mouse ornithine decarboxylase confers rapid degradation on dihydrofolate reductase. Support for the pest hypothesis J Biol Chem 266 11213–11220 Occurrence Handle1:CAS:528:DyaK3MXksVCgurw%3D Occurrence Handle2040628
B Moss (1996) ArticleTitleGenetically engineered poxviruses for recombinant gene expression, vaccination, and safety Proc Natl Acad Sci USA 93 11341–11348 Occurrence Handle10.1073/pnas.93.21.11341 Occurrence Handle1:CAS:528:DyaK28Xmtlagsrw%3D Occurrence Handle8876137
P Potter S Tourdot T Blanchard GL Smith KG Gould (2001) ArticleTitleDifferential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein J Gen Virol 82 1069–1074 Occurrence Handle1:CAS:528:DC%2BD3MXjtFOisb8%3D Occurrence Handle11297681
Rokitsky PF (1964) Biological statistics. Vysshaya shkola, Minsk, USSR (in Russian)
LL Shu WJ Bean RG Webster (1993) ArticleTitleAnalysis of the evolution and variation of the human influenza A virus nucleoprotein gene from 1933 to 1990 J Virol 67 2723–2729 Occurrence Handle1:CAS:528:DyaK3sXltlals7o%3D Occurrence Handle8474171
YA Smirnov AS Lipatov R Van Beek AK Gitelman AD Osterhaus EC Claas (2000) ArticleTitleCharacterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host Acta Virol 44 1–8 Occurrence Handle1:CAS:528:DC%2BD3cXjs1ajur0%3D Occurrence Handle10989685
GL Smith JZ Levin P Palese B Moss (1987) ArticleTitleSynthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses Virology 160 336–345 Occurrence Handle1:CAS:528:DyaL2sXmtFaqsL4%3D Occurrence Handle3310381
I Stephenson KG Nicholson JM Wood MC Zambon JM Katz (2004) ArticleTitleConfronting the avian influenza threat: vaccine development for a potential pandemic Lancet Infect Dis 4 499–509 Occurrence Handle1:CAS:528:DC%2BD2cXntF2ksbw%3D Occurrence Handle15288823
L Stitz C Schmitz D Binder R Zinkernagel E Paoletti H Becht (1990) ArticleTitleCharacterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection J Gen Virol 71 1169–1179 Occurrence Handle1:CAS:528:DyaK3cXkt1Wru7o%3D Occurrence Handle1693165 Occurrence Handle10.1099/0022-1317-71-5-1169
A Townsend J Bastin K Gould G Brownlee M Andrew B Coupar D Boyle S Chan G Smith (1988) ArticleTitleDefective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen J Exp Med 168 1211–1224 Occurrence Handle10.1084/jem.168.4.1211 Occurrence Handle1:CAS:528:DyaL1cXmt1yis7Y%3D Occurrence Handle2459295
JB Ulmer (2002) ArticleTitleInfluenza DNA vaccines Vaccine 20 IssueID[Suppl] 2 74–76
RG Webster Y Kawaoka J Taylor R Weinberg E Paoletti (1991) ArticleTitleEfficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens Vaccine 9 303–308 Occurrence Handle10.1016/0264-410X(91)90055-B Occurrence Handle1:STN:280:By6A3srosFQ%3D Occurrence Handle1651609
RD Wesley M Tang KM Lager (2004) ArticleTitleProtection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus Vaccine 22 3427–3434 Occurrence Handle10.1016/j.vaccine.2004.02.040 Occurrence Handle1:CAS:528:DC%2BD2cXmsl2js7o%3D Occurrence Handle15308368
DC Wraith AE Vessey BA Askonas (1987) ArticleTitlePurified influenza virus nucleoprotein protects mice from lethal infection J Gen Virol 68 433–440 Occurrence Handle1:CAS:528:DyaL2sXhsFCgurg%3D Occurrence Handle3493324
Wright P, Webster RG (2001) Orthomyxoviruses. In: Knipe DM, Howley PM (eds) Fields virology, vol 1. Lippincot, Williams, Wilkins, Philadelphia, USA, pp 1533–1579
JW Yewdell JR Bennink GL Smith B Moss (1985) ArticleTitleInfluenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes Proc Natl Acad Sci USA 82 1785–1789 Occurrence Handle1:CAS:528:DyaL2MXktlGktL8%3D Occurrence Handle3872457
J Yewdell LC Anton I Bacik U Schubert HL Snyder JR Bennink (1999) ArticleTitleGenerating MHC class I ligands from viral gene products Immunol Rev 172 97–108 Occurrence Handle1:CAS:528:DC%2BD3cXkvValtA%3D%3D Occurrence Handle10631940
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Altstein, A., Gitelman, A., Smirnov, Y. et al. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Arch Virol 151, 921–931 (2006). https://doi.org/10.1007/s00705-005-0676-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-005-0676-9